Global technology corporation FPT and Global ICT leader Ericsson have entered a partnership to accelerate 5G adoption and ...

In its report, Forrester, a leading global research and advisory firm, “defines SAP services providers as: SAP-certified ...

Oakio, a global leader in eco-friendly and high-performance wood-plastic composite (WPC) products, announces its participation in BAU 2025, the world's premier trade fair for architecture, materials, ...

Recent launches of AI PCs for the global market with Lenovo AI Now have also been received positively. For enterprise AI, the Group is leveraging its full-stack hybrid infrastructure as well as Lenovo ...

Celltrion (KRX:068270), a global biopharmaceutical leader, announced its acquisition of iQone Healthcare Switzerland, a specialty pharmaceutical company focused on distribution, sales, and marketing ...

Conexus MedStaff, a leader in international healthcare recruitment, is proud to partner with Taimaka, an organization providing critical malnutrition care to children in Gombe state, Nigeria.

NTT DATA, a global digital business and IT services leader, today released the first results of its extensive original research that reveals “playtime is over” for GenAI. The results overwhelmingly ...

With the launch of Brightcove Marketing Studio for Sales, the leading video engagement platform for enterprises is now even more powerful. Sales teams can quickly and easily create custom, branded ...

For the first time, Allianz placed among the 25 World's Best Workplaces 2024™ at #17. The respected annual employer ranking conducted by Great Place To Work ® measures trust in employers and is based ...

Andersen Global strengthens its platform in New Zealand through a Collaboration Agreement with Three Sixty Capital Partners, a strategic M&A advisory firm based in Auckland.

The X-ray Laboratory of Rigaku Corporation, a Rigaku Holdings Group company and a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), ...

Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...